Source:http://linkedlifedata.com/resource/pubmed/id/20110918
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-1-29
|
pubmed:abstractText |
Glucose has been the main osmole used in conventional peritoneal fluids (PDFs) since the beginning of continuous ambulatory peritoneal dialysis (CAPD). There is much concern regarding the possible risk to the good level of glycemia control lately observed. The aim of this study was to analyze, with the use of 72-hour continuous glucose monitoring system (CGMS), the influence of PDFs containing supra-physiological glucose concentrations on daily glucose profile in patients with end stage renal disease (ESRD) undergoing CAPD therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1643-3750
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CR75-83
|
pubmed:meshHeading |
pubmed-meshheading:20110918-Biological Transport,
pubmed-meshheading:20110918-Blood Glucose,
pubmed-meshheading:20110918-Blood Glucose Self-Monitoring,
pubmed-meshheading:20110918-Case-Control Studies,
pubmed-meshheading:20110918-Circadian Rhythm,
pubmed-meshheading:20110918-Female,
pubmed-meshheading:20110918-Humans,
pubmed-meshheading:20110918-Kidney Failure, Chronic,
pubmed-meshheading:20110918-Male,
pubmed-meshheading:20110918-Middle Aged,
pubmed-meshheading:20110918-Peritoneal Dialysis, Continuous Ambulatory,
pubmed-meshheading:20110918-Peritonitis
|
pubmed:year |
2010
|
pubmed:articleTitle |
Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis.
|
pubmed:affiliation |
Department of Internal Medicine, Diabetology and Nephrology, Medical University of Silesia, Zabrze, Poland.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|